{{YIELDBOT INTENT TAGS}} {{RUBICON REAL TIME}}
May 2007: Chromium and Biotin for Diabetes
all information

May 2007: Chromium and Biotin for Diabetes

image for womens diabetes article The mineral chromium is often suggested as a treatment for type 2 diabetes . However, study results have been inconsistent, showing marginal benefits at most. The results of a very large study published online in May 2007 suggest that a combination of chromium and biotin may be more clearly helpful.

This double-blind study included 447 people with poorly controlled type 2 diabetes. Half the participants were given placebo and the rest were given 600mg of chromium (as chromium picolinate) along with 2 mg of biotin daily. All participants continued to receive standard oral medications for diabetes.

Over the ninety-day study period, participants given the chromium/biotin combination showed significantly better glucose regulation than those given placebo. The relative benefit was demonstrated through measurement of fasting glucose, an indicator of day-to-day blood sugar control, as well as HgbA1c, a marker for long-term glucose control.

For more information, see the full articles on diabetes , chromium , and biotin .

References:

Albarracin CA, Fuqua BC, Evans JL, et al. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev . 2007 May 16 [Epub ahead of print].



Last reviewed May 2007 by Steven Bratman, MD

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.


Your Health and Happiness


DiggDeliciousNewsvineRedditStumbleTechnoratiFacebook